Urinary 11-dehydro-thromboxane B2 and coagulation activation markers measured within 24 h of human acute ischemic stroke

[1]  P. Koudstaal,et al.  Platelet activation and lipid peroxidation in patients with acute ischemic stroke. , 1997, Stroke.

[2]  R. Tracy,et al.  Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. , 1997, Stroke.

[3]  M. Sata,et al.  Protein C activation in NIDDM patients , 1996, Diabetologia.

[4]  W. Feinberg,et al.  Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome. , 1996, Stroke.

[5]  H. Asakura,et al.  Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. , 1996, Atherosclerosis.

[6]  A. Terashi,et al.  Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation. , 1995, Stroke.

[7]  Rugman Fp,et al.  Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors. , 1994 .

[8]  R. Fanelli,et al.  Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. , 1993, Clinical chemistry.

[9]  J. V. van Wersch,et al.  Prothrombin fragment 1.2 in both treated and untreated hypertensive patients. , 1993, The Netherlands journal of medicine.

[10]  R. Fanelli,et al.  Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. , 1993, Prostaglandins.

[11]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[12]  K. Takano,et al.  Markers of a hypercoagulable state following acute ischemic stroke. , 1992, Stroke.

[13]  M. Fisher,et al.  Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity. , 1990, Archives of neurology.

[14]  G. Davı̀,et al.  Thromboxane biosynthesis and platelet function in type II diabetes mellitus. , 1990, The New England journal of medicine.

[15]  R. Barbarotto,et al.  Prognostic significance of fibrinopeptide A in survivors of cerebral infarction. , 1990, Stroke.

[16]  C. Dollery,et al.  Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. , 1989, Biochimica et biophysica acta.

[17]  G. FitzGerald,et al.  Paired analysis of urinary thromboxane B2 metabolites in humans. , 1987, Thrombosis research.

[18]  B. Coull,et al.  Enhanced in vivo platelet activation in subtypes of ischemic stroke. , 1985, Stroke.

[19]  J. Fontcuberta,et al.  Hemostatic disturbances in acute ischemic stroke: a study of 86 patients. , 1995, Acta haematologica.

[20]  J. V. van Wersch,et al.  Plasma Concentration of Coagulation and Fibrinolysis Factors and Platelet Function in Hypertension , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.